The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The chemokine SDF‐lα triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway
Open accessAbstract
The chemokine stromal cell‐derived factor (SDF‐1α), the ligand for the CXCR4 receptor, induces a wide variety of effects that include calcium mobilization, chemotactic responses, bone marrow myelopoiesis, neuronal patterning, and prevention of HIV‐1 infection. Nonetheless, little is known of the biochemical pathways required to achieve this variety of responses triggered after receptor—chemokine interaction. We developed a set of monoclonal antibodies that specifically recognize the CXCR4 receptor and used them to identify the signaling pathway activated after SDF‐1α binding in human T cell lines. Here we demonstrate that SDF‐1α activation promotes the physical association of Gα i with the CXCR4. Furthermore, within seconds of SDF‐1α activation, the CXCR4 receptor becomes tyrosine phosphorylated through the activation and association with the receptor of JAK2 and JAK3 kinases. After SDF‐1α binding, JAK2 and JAK3 associate with CXCR4 and are activated, probably by transphosphorylation, in a Gα i ‐independent manner. This activation enables the recruitment and tyrosine phosphorylation of several members of the STAT family of transcription factors. Finally, we have also observed SDF‐1α‐induced activation and association of the tyrosine phosphatase Shpl with the CXCR4 in a Gα i ‐dependent manner. As occurs with the cytokine receptors in response to cytokines, the CXCR4 undergoes receptor dimerization after SDF‐1α binding and is a critical step in triggering biological responses. We present compelling evidence that the chemokines signal through mechanisms similar to those activated by cytokines.—Vila‐Coro, A. J., Rodríguez‐Frade, J. M., Martín de Ana, A., Moreno‐Ortíz, M. C., Martínez‐A., C., Mellado, M. The chemokine SDF‐1 α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J . 13, 1699–1710 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013 · cited 1×
“fractalkine is a CX3C chemokine with a long mucinlike stalk and a transmembrane region (4).”
BackgroundRollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Cited by
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
“…$15.00 www.nature.com/onc *Correspondence: JE Darnell Jr routes of STAT activation have been reported such as G-protein signaling and angiotensin binding to its 7- transmembrane receptor probably through Jak kinase activation (Marrero et al., 1995; Vila-Coro et al., 1999; Wong and Fish, 1998).”
BackgroundInfluentialKucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0342 · Cited by 759
Alexander, W. S., & Hilton, D. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.091003.090312 · Cited by 701
CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698
The Intricate Role of CXCR4 in Cancer
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-411638-2.00002-1 · Cited by 672
Dancing to the tune of chemokines
Thelen, M. (2001) · Nature Immunology · doi:10.1038/84224 · Cited by 618
Busillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
G-Protein-coupled receptor oligomerization and its potential for drug discovery
George, S. R., O'Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 588
Dimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology
Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474
Mercier, J.-F., Salahpour, A., Angers, S., Breit, A., & Bouvier, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205767200 · Cited by 473
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
Mellado, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2497 · Cited by 432
Self-citationThe pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 424
Chemokines and Their Receptors in the Central Nervous System
Bajetto, A., Bonavia, R., Barbero, S., Florio, T., & Schettini, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0214 · Cited by 416
Geminder, H., Sagi-Assif, O., Goldberg, L., Meshel, T., Rechavi, G., Witz, I. P., & Ben-Baruch, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4747 · Cited by 409
Mellado, M., Rodríguez-Frade, J. M., Mañes, S., & Martínez-A, C. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.397 · Cited by 390
Self-citationThe unique structural and functional features of CXCL12
Janssens, R., Struyf, S., & Proost, P. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.107 · Cited by 378
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Bousoik, E., & Montazeri Aliabadi, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00287 · Cited by 376
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E. I., Hackeng, T. M., & Weber, C. (2005) · Blood · doi:10.1182/blood-2004-06-2475 · Cited by 373
LI, M., & RANSOHOFF, R. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.11.003 · Cited by 352
The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration
Bianchi, M. E., & Mezzapelle, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02109 · Cited by 335
Walter, D. H., Haendeler, J., Reinhold, J., Rochwalsky, U., Seeger, F., Honold, J., Hoffmann, J., Urbich, C., Lehmann, R., Arenzana-Seisdesdos, F., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000193596.94936.2c · Cited by 329
The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
Sánchez-Martín, L., Estecha, A., Samaniego, R., Sánchez-Ramón, S., Vega, M. Á., & Sánchez-Mateos, P. (2011) · Blood · doi:10.1182/blood-2009-12-258186 · Cited by 325
Hu, X., Dai, S., Wu, W.-J., Tan, W., Zhu, X., Mu, J., Guo, Y., Bolli, R., & Rokosh, G. (2007) · Circulation · doi:10.1161/circulationaha.106.672451 · Cited by 319
Bajetto, A., Bonavia, R., Barbero, S., & Schettini, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01091.x · Cited by 318
Biased Receptor Signaling in Drug Discovery
Kenakin, T. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016790 · Cited by 294
Cell migration during morphogenesis
Aman, A., & Piotrowski, T. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2009.11.014 · Cited by 292
Functions of CXCL12 and CXCR4 in breast cancer
Luker, K. E., & Luker, G. D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.021 · Cited by 288
Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Zhou, W., Guo, S., Liu, M., Burow, M. E., & Wang, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170830111531 · Cited by 278
The functional significance behind expressing two IL–8 receptor types on PMN
Stillie, R., Farooq, S. M., Gordon, J. R., & Stadnyk, A. W. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208125 · Cited by 272
Chemokines: attractive mediators of the immune response
Wong, M. M., & Fish, E. N. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00123-9 · Cited by 266
Sriram, K., Benkovic, S. A., Hebert, M. A., Miller, D. B., & O'Callaghan, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309304200 · Cited by 261
Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M., & Heveker, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411151200 · Cited by 261
McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., & Milligan, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008902200 · Cited by 257
CXCR4 signaling in health and disease
Pozzobon, T., Goldoni, G., Viola, A., & Molon, B. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.006 · Cited by 256
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Dubrovska, A., Cojoc, M., Peitzsch, Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 254
The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond
Ullah, T. R. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2019.100253 · Cited by 141
Redelman, D., Welniak, L. A., Taub, D., & Murphy, W. J. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.12.003 · Cited by 71
Altenburg, J. D., & Siddiqui, R. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0385 · Cited by 67
Wang, M., Liu, Y., Cheng, Y., Wei, Y., & Wei, X. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.12.002 · Cited by 66
Kim, E., Cheng, Y., Bolton-Gillespie, E., Cai, X., Ma, C., Tarangelo, A., Le, L., Jambhekar, M., Raman, P., Hayer, K. E., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160719 · Cited by 18
Metadata
- Authors
- Vila‐Coro, A. J., Rodríguez‐Frade, J. M., De Ana, A. M., Moreno‐Ortíz, M. C., Martínez‐A., C., & Mellado, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 13
- Issue
- 13
- Pages
- 1699-1710
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1922502842
- Cited by
- 506
- References
- 47
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.